Percutaneous drainage of pancreatic collections has recently been advo
cated as a means of diagnosis of bacterial contamination, for temporiz
ing unstable patients, and as definitive treatment in itself In order
to assess its efficacy, the role of percutaneous drainage of infected
pancreatic fluid collections was retrospectively reviewed by a single
surgical practice. Seventeen patients were treated over a 5-year perio
d from 1987 to 1992. All patients admitted or referred with a diagnosi
s of infected peripancreatic fluid collection were included in the rev
iew. The group consisted of eleven males and six females; mean age was
55.2 years (range 28 to 70). Patients were stratified into one of two
groups based on initial treatment modality. Group A consisted of eigh
t patients treated initially with percutaneous drainage as presumed de
finitive management. Eight patients in Group B were treated initially
with surgical debridement and drainage. APACHE II scores on admission
were 5.62 +/- 3.66 for Group A and 9.12 +/- 3.87 for Group B (N.S.). M
ean hospital stay was 100 days (range 13-311) for Group A and 71 (rang
e 25-149) for Group B (N.S.). Despite initial percutaneous drainage, s
ix of eight (75%) patients in Group A required operative debridement b
ecause of clinical deterioration. APACHE II scores in this subset went
from 6.83 +/- 3.43 to 9.83 +/- 5.04 (N.S.) despite a total of 18 preo
perative percutaneous procedures (2.25 per patient; range 1-7). The nu
mber of complications for this group totaled 15. Five of the six patie
nts with positive cultures from their initial aspiration failed percut
aneous drainage. Patients in Group A required an average of 1.44 opera
tive debridements per patient (range 1-3); those in Group B, who were
treated initially with surgical debridement, averaged 2.0 per patient
(range 1-7) (N.S.). Five patients in Group A suffered a total of 15 co
mplications. There was one mortality in this group (63% morbidity, 13%
mortality). Seven patients in Group B suffered a total of 17 complica
tions, with two deaths occuring in this group (88% morbidity, 25% mort
ality) (N.S.). Based on our experience, percutaneous drainage of infec
ted pancreatic collections should not be used as initial therapy. This
approach leads to a trend of clinical deterioration and higher mortal
ity, not to stabilization or improvement There is also a trend toward
prolonged hospital stay in the group treated initially with percutaneo
us drainage. Operative debridement was ultimately required in the majo
rity of these patients. Documentation of bacterial contamination was a
strong predictor of the need for eventual surgical debridement. An ag
gressive approach of early surgical debridement for patients presentin
g with infected pancreatic fluids collections is recommended.